Lepidico Ltd (ASX:LPD) (“Lepidico” or “Company”) is pleased to announce that it has now received a United States Patent for its 100% owned L-Max® process technology. This follows the Company’s announcement of 16 September 2019 that the United States Patent and Trademark Office had advised it had issued a Notice of Allowance for the L-Max® process under International Patent Application PCT/AU2015/000608. National and regional phase patent applications are now well advanced in other key jurisdictions where patent protection for L-Max® is being sought.
Patent protection now received for L-Max® in the USA
PCT International Patent Applications for L-Max® in other key jurisdictions are well advanced
For further information please download the attached PDF:
Download this document